Back
ESC Premium Access

Treatment of ARVC: current standards and future perspectives

Session: Arrhythmogenic cardiomyopathy: From pathology to prognosis
Topic: Arrhythmogenic Right Ventricular Cardiomyopathy
Speaker: Professor T. Wichter (Osnabrück, DE)
Event: ESC Congress 2018

Congress Presentation

About the speaker

Professor Thomas Wichter

Niels-Stensen-Clinics - Marienhospital Osnabruck, Osnabrück (Germany)
1 presentation
0 follower

4 more presentations in this session

Pathogenesis of ARVC - State of the art

Speaker: Professor E. Arbustini (Pavia, IT)

Access
Slides
Video
Thumbnail

Arrhythmogenic cardiomyopathy: a paradigm shift of the morphologic spectrum

Speaker: Doctor M. De Gaspari (Padua, IT)

Access
Abstract
Slides
Video
Thumbnail

Anti-heart autoantibodies and arrhythmogenic cardiomyopathy: the role of inflammation in disease evolution

Speaker: Doctor G. Halasz (Lugano, IT)

Access
Abstract
Slides
Video
Thumbnail

Multimodality prediction of life-threatening ventricular arrhythmia in patients with arrhythmogenic cardiomyopathy; a prospective cohort study

Speaker: Doctor O. Lie (Oslo, NO)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Arrhythmogenic cardiomyopathy: From pathology to prognosis

Speakers: Professor T. Wichter, Professor E. Arbustini, Doctor M. De Gaspari, Doctor G. Halasz, Doctor O. Lie
Access
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb